Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning

被引:112
|
作者
Wysocki, CA
Burkett, SB
Panoskaltsis-Mortari, A
Kirby, SL
Luster, AD
McKinnon, K
Blazar, BR
Serody, JS
机构
[1] Univ N Carolina, Lineberger Canc Res Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Microbiol, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Dept Immunol, Chapel Hill, NC 27599 USA
[5] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
[6] Div Pediat Bone Marrow Transplantat, Dept Pediat, Minneapolis, MN 55455 USA
[7] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02129 USA
[8] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02129 USA
[9] Harvard Univ, Sch Med, Boston, MA 02129 USA
来源
JOURNAL OF IMMUNOLOGY | 2004年 / 173卷 / 02期
关键词
D O I
10.4049/jimmunol.173.2.845
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The coordinated expression of chemokines and receptors may be important in the directed migration of alloreactive T cells during graft-vs-host disease (GVHD). Recent work demonstrated in a murine model that transfer of CCR5-deficient (CCR5(-/-)) donor cells to nonconditioned haploidentical recipients resulted in reduced donor cell infiltration in liver and lymphoid tissues compared with transfer of CCR5(+/+) cells. To investigate the function of CCR5 during. GVHD in conditioned transplant recipients, we transferred CCR5(-/-) or wild-type C57BL/6 (136) T cells to lethally irradiated B6D2 recipients. Unexpectedly, we found an earlier time to onset and a worsening of GVHD using CCR5-/- T cells, which was associated with significant increases in the accumulation of alloreactive CD4(+) and CD8(+) T cells in liver and lung. Conversely, the transfer of CCR5(-/-) donor cells to nonirradiated recipients led to reduced infiltration of target organs, confirming previous studies and demonstrating that the role of CCR5 on donor T cells is dependent on conditioning of recipients. Expression of proinflammatory chemokines in target tissues was dependent on conditioning of recipients, such that CXCL10 and CXCL11 were most highly expressed in tissues of irradiated recipients during the first week post-transplant. CCR5(-/-) T cells were shown to have enhanced migration to CXCL10, and blocking this ligand in vivo improved survival in irradiated recipients receiving CCR5-/- T cells. Our data indicate that the effects of inhibiting CCR5/ligand interaction on donor T cells during GVHD differ depending on conditioning of recipients, a finding with potentially important clinical significance.
引用
收藏
页码:845 / 854
页数:10
相关论文
共 50 条
  • [1] Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease
    Wysocki, CA
    Jiang, Q
    Panoskaltsis-Mortari, A
    Taylor, PA
    McKinnon, KP
    Su, LS
    Blazar, BR
    Serody, JS
    BLOOD, 2005, 106 (09) : 3300 - 3307
  • [2] Immunologic Effects of CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis
    Moy, Ryan H.
    Huffman, Austin P.
    Richman, Lee P.
    Crisalli, Lisa
    Hoxie, James A.
    Vonderheide, Robert H.
    Porter, David L.
    Reshef, Ran
    BLOOD, 2015, 126 (23)
  • [3] Alterations in Chemokine Receptor CCR5 Expression on Blood Dendritic Cells Correlate With Acute Graft-Versus-Host Disease
    Shahin, Kifah
    Sartor, Mary
    Hart, Derek N. J.
    Bradstock, Kenneth F.
    TRANSPLANTATION, 2013, 96 (08) : 753 - 762
  • [4] CCR5 Expression on Cells from HLA-Matched Unrelated Marrow Donors and Graft-versus-Host Disease
    Ma, Qing
    Gooley, Ted A.
    Storb, Rainer F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (01) : 132 - 133
  • [5] Expression of CCR5 in graft-versus-host disease (GVHD) of the skin: Immunohistochemical staining of 38 cases
    Morita, Naoko I.
    Matsumura, Yumi
    Morita, Kazumasa
    Miyachi, Yoshiki
    JOURNAL OF DERMATOLOGY, 2007, 34 (04): : 254 - 257
  • [6] Chemokine Receptor CCR5 Mediates AlloImmune Responses in Graft-versus-Host Disease
    Palmer, Lisa A.
    Sale, George E.
    Balogun, John I.
    Li, Dan
    Jones, Dan
    Molldrem, Jeffrey J.
    Storb, Rainer F.
    Ma, Qing
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (03) : 311 - 319
  • [7] Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis
    Moy, Ryan H.
    Huffman, Austin P.
    Richman, Lee P.
    Crisalli, Lisa
    Wang, Ximi K.
    Hoxie, James A.
    Mick, Rosemarie
    Emerson, Stephen G.
    Zhang, Yi
    Vonderheide, Robert H.
    Porter, David L.
    Reshef, Ran
    BLOOD, 2017, 129 (07) : 906 - 916
  • [8] Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease Prophylaxis
    Huffman, Austin P.
    Richman, Lee P.
    Crisalli, Lisa
    Ganetsky, Alex
    Porter, David L.
    Vonderheide, Robert H.
    Reshef, Ran
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : 594 - 599
  • [9] Extended CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis - a Phase ll Study
    Reshef, Ran
    Mangan, James K.
    Luger, Selina M.
    Loren, Alison Wakoff
    Hexner, Elizabeth O.
    Frey, Noelle V.
    Stadtmauer, Edward A.
    Blauser, Robin E.
    Richman, Lee P.
    Huffman, Austin P.
    Ganetsky, Alex
    Acosta, Edward P.
    Hoxie, James A.
    Mick, Rosemarie
    Vonderheide, Robert H.
    Porter, David L.
    BLOOD, 2014, 124 (21)
  • [10] Prevention of Graft-Versus-Host Disease by Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist
    Reshef, Ran
    Luger, Selina M.
    Loren, Alison W.
    Frey, Noelle V.
    Goldstein, Steven C.
    Hexner, Elizabeth O.
    Stadtmauer, Edward A.
    Smith, Jacqueline
    Mick, Rosemarie
    Heitjan, Daniel F.
    Shetzline, Susan E.
    Danet-Desnoyers, Gwenn-ael H.
    Emerson, Stephen G.
    Hoxie, James A.
    Vonderheide, Robert H.
    Porter, David L.
    BLOOD, 2010, 116 (21) : 295 - 296